mRNA |
AC220 |
GDSC1000 |
pan-cancer |
AAC |
0.068 |
0.06 |
mRNA |
lapatinib |
FIMM |
pan-cancer |
AAC |
0.3 |
0.06 |
mRNA |
BHG712 |
GDSC1000 |
pan-cancer |
AAC |
0.058 |
0.07 |
mRNA |
Erlotinib |
gCSI |
pan-cancer |
AAC |
0.11 |
0.07 |
mRNA |
navitoclax:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.064 |
0.07 |
mRNA |
Rapamycin |
CTRPv2 |
pan-cancer |
AAC |
-0.065 |
0.07 |
mRNA |
BRD-K27188169:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.099 |
0.07 |
mRNA |
(5Z)-7-Oxozeaenol |
GDSC1000 |
pan-cancer |
AAC |
0.06 |
0.07 |
mRNA |
JQ-1:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.064 |
0.07 |
mRNA |
CHM-1 |
CTRPv2 |
pan-cancer |
AAC |
-0.06 |
0.07 |